Fish oil reached the brain. A two-year trial did not find the hoped-for memory benefit.
In older adults at increased dementia risk, high-dose DHA did not show significant cognitive or hippocampal protection compared with placebo.
A two-year trial has challenged a simple assumption about brain-health supplements: getting more of a nutrient into the central nervous system does not automatically improve memory. Researchers reported that high-dose DHA reached its target but did not deliver the measured cognitive benefit hoped for in the group studied.
Who took part
The trial described in ScienceDaily enrolled 365 adults aged 55 to 80 who rarely ate fish and were considered at increased risk of Alzheimer’s disease. Nearly half carried the APOE4 gene variant, which is associated with higher risk but does not make dementia inevitable.
Participants were randomly assigned to daily supplements providing 2,000 milligrams of DHA or a placebo. The double-blind design meant participants and researchers did not know who was receiving the active supplement during the trial. The findings were published in eBioMedicine.
A biological change without the expected benefit
After six months, the supplement group’s DHA concentration in cerebrospinal fluid had risen by an average of 17 percent. That offered evidence of central-nervous-system target engagement—an important step, but not the same thing as demonstrating a health benefit.
At two years, researchers did not find a significant cognitive advantage over placebo or protection against shrinkage of the hippocampus, an area important to memory. The result concerns the dose, population, duration and outcomes tested; it is not proof that every omega-3 intervention has identical effects.
What readers should not infer
The findings do not mean omega-3 fatty acids are unnecessary, that fish has no nutritional value or that all reasons for prescribing omega-3 products have been disproved. They also do not establish that a different diet prevents dementia; broader dietary explanations remain separate from what this trial directly tested.
For readers, the useful distinction is between an essential nutrient and a supplement proven to prevent a particular disease. Anyone using a prescribed product should discuss changes with their clinician rather than stop treatment because of a headline about memory research.
